The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-bromo-4-morpholino-anilino)-2-oxo-ethanesulfonic acid ID: ALA5220114
Chembl Id: CHEMBL5220114
PubChem CID: 168298621
Max Phase: Preclinical
Molecular Formula: C12H15BrN2O5S
Molecular Weight: 379.23
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CS(=O)(=O)O)Nc1ccc(N2CCOCC2)c(Br)c1
Standard InChI: InChI=1S/C12H15BrN2O5S/c13-10-7-9(14-12(16)8-21(17,18)19)1-2-11(10)15-3-5-20-6-4-15/h1-2,7H,3-6,8H2,(H,14,16)(H,17,18,19)
Standard InChI Key: OGEMZMYUTTZMCI-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.23Molecular Weight (Monoisotopic): 377.9885AlogP: 1.11#Rotatable Bonds: 4Polar Surface Area: 95.94Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: -2.27CX Basic pKa: ┄CX LogP: -0.50CX LogD: -1.31Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.76Np Likeness Score: -1.67
References 1. He R, Wang J, Yu ZH, Moyers JS, Michael MD, Durham TB, Cramer JW, Qian Y, Lin A, Wu L, Noinaj N, Barrett DG, Zhang ZY.. (2022) Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors., 65 (20.0): [PMID:36197449 ] [10.1021/acs.jmedchem.2c01143 ]